WXXWY:OTCMKTS
Wuxi Biologics Cayman ADR
12,56Â $
arrow_upward
+0,48%(+0,060) 1 p
16. okt, 16:00:00 GMT −4 · USD
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse WXXWY põhistatistika genereerimine…
Ava
12,29Â $
Kõrge
12,56Â $
Madal
12,20Â $
Turu kapit.
198,43Â mld
Keskm. maht
61,89Â tuh
Maht
110,85Â tuh
52 näd kõrgeim
14,80Â $
52 näd madalaim
7,30Â $
Beeta
0,01
Käibivad aktsiad
2,06Â mld
Töötajate arv
15Â tuh
Ava
12,29Â $
Kõrge
12,56Â $
Madal
12,20Â $
Turu kapit.
198,43Â mld
Keskm. maht
61,89Â tuh
Maht
110,85Â tuh
52 näd kõrgeim
14,80Â $
52 näd madalaim
7,30Â $
Beeta
0,01
Käibivad aktsiad
2,06Â mld
Töötajate arv
15Â tuh
Uudised
Veebiallikatest ja uudistepartneritelt
Foreign Policy Journal
·
22 minuti eest
Super Micro Computer (NASDAQ: SMCI) Signals Were Visible Before Its Stock 45% Rally
Yahoo Finance
·
11 tunni eest
Michael Burry Warns of a Stock Market ‘Supervolcano’
AOL.com
·
7 tunni eest
Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors.
MarketWatch
·
6 tunni eest
These surprising stocks could be some of the biggest drivers of S&P 500 earnings growth
Profiil
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Teave üksuse Wuxi Biologics Cayman ADR kohta